Endocrinology, Diabetes & Metabolism Case Reports (Dec 2022)

Tumor-induced osteomalacia treated with T12 tumor resection

  • Alyssa J Mancini,
  • Amin Sabet,
  • Gunnlaugur Petur Nielsen,
  • J Anthony Parker,
  • Joseph H Schwab,
  • Ashley Ward,
  • Jim S Wu,
  • Alan O Malabanan

DOI
https://doi.org/10.1530/EDM-22-0344
Journal volume & issue
Vol. 1, no. 1
pp. 1 – 6

Abstract

Read online

Tumor-induced osteomalacia (TIO) is a rare form of osteomalacia caused by fibroblast growth factor-23 (FGF23)- secreting tumors. Most of these tumors are phosphaturic mesenchymal tumors (PMTs) typically involving soft tissue in the extremities and bone of the appendicular skeleton and cranium. We report the case of a 60-year-old woman with about 3 years of persistent bone pain and multiple fractures, initially diagnosed as osteoporosis, who was found to have hypophosphatemia with low 1,25-dihydroxyvitamin D and elevated alkaline phosphatase and inappropriately normal FGF23 consistent with TIO. Her symptoms improved with phosphate supplementation, vitamin D and calcitriol. 68Ga-DOTATATE imaging revealed a T12 vertebral body lesion confirmed on biopsy to be a PMT. She underwent resection of the PMT with resolution of TIO and increased bone density. This rare case of TIO secondary to a PMT of the thoracic spine highlights some of the common features of PMT-associated TIO and draws attention to PMT-associated TIO as a possible cause of unexplained persistent bone pain, a disease entity that often goes undiagnosed and untreated for years.